All Newsletters

Leftfield Investing

Visit Newsletter

Leftfield Investing has 35 stock analyses indexed on RhinoInvestory, covering 28 companies across Consumer Discretionary, Health Care, Industrials and 1 more. Published Dec 2022 – Aug 2026.

Sectors Covered

Consumer Discretionary Health Care Industrials Information Technology

Countries Covered

Canada Sweden US

Stock Analyses by Leftfield Investing

Replimune recieves accelerated approval

Replimune Group ($REPL) • 2026-08-07

PDEX hits $67 USD/share

Pro-Dex, Inc. ($PDEX) • 2026-08-04

Clearpoint Neuro 5 years of reflection

ClearPoint Neuro ($CLPT) • 2026-08-04

Vaso sells a subsidiary, shares close 38% higher

Vaso Corporation ($VASO) • 2026-08-04

Zedcor has been integrated into direct to dispatch

Zedcor ($ZDC.V) • 2026-08-03

A busted acquisition has made Galaxy Gaming incredibly cheap

Galaxy Gaming, Inc. ($GLXZ) • 2026-07-29

Ken Dart triggers mandatory bid for Evolution Gaming

Evolution AB ($EVVTY) • 2026-07-28

SINTEFs commercial waste refuge into Flerie AB with BSG005

Flerie ($FLERIE.ST) • 2026-07-19

IGaming - Evolution Gaming hurdle rate is well positioned & a prospective buyout in 3 years time.

Evolution AB ($EVVTY) • 2026-07-16

Medicare part D coverage started July 1st is rapidly eroding Pepsi Co's profit center in American snacks.

Pepsi • 2026-07-10

Monogram highlights from the Goldman Sachs 47th Annual Global Healthcare Conference

Monogram • 2026-07-07

Tarsus Pharmaceuticals Lotilaner, a soon to be blockbuster with an Achilles' heel

Tarsus Pharmaceuticals • 2026-07-03

Abivax is a lesson

Abivax • 2026-07-01

Zedcor expands into the desert & is now using drones, uniQure gets a BLA submission, Pro-Dex inc reveals further details about Monogram in Vegas.

Zedcor ($ZDC.V) • 2026-06-24

Planet Microcap & Zimmer Biomet Q1

Planet Microcap • 2026-05-25

Evolutions €2B buyback program.

Evolutions • 2026-05-24

An aging Huntingtons patient treated with AMT-130 goes off disability

AMT-130 • 2026-05-23

Zedcor's latest quarter

Zedcor ($ZDC.V) • 2026-05-22

What's going to be offered by Zimmer Biomet is largely unbeatable and an early example of applied AI in robotics materially impacting a significant labor market.

Zimmer Biomet • 2026-05-16

Fervo IPO @ $27 USD, indicating an OPEN at $40 USD

Fervo • 2026-05-13